课题基金 / 基金详情

An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke

An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke
一项澳大利亚、多中心、随机、双盲、安慰剂对照试验,探讨氟西汀改善急性中风后功能恢复的功效
批准号:
nhmrc : 1059094
负责人:
A/Pr Christopher Etherton-Beer
金额:
$153.79万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2018-12-31

项目摘要

项目成果

A/Pr Christopher Etherton-Beer的其他基金

相似基金

相关文献

中文摘要
翻译
中风是导致残疾的三大原因之一。缺乏改善中风后恢复的治疗方法。我们回顾了世界文献,发现了一些非常小的研究,这些研究共同表明抗抑郁药氟西汀可以改善中风患者的恢复。AFFINITY是一项在1600名澳大利亚和新西兰中风患者中进行的大型试验,旨在确定与安慰剂相比,中风后服用氟西汀6个月是否能改善恢复。
英文摘要
Stroke is one of the top three causes of disability. Treatments that improve recovery after stroke are lacking. We reviewed the world literature and found a number of very small studies which, together, suggest that the antidepressant drug, fluoxetine, may improve the recovery in stroke patients. AFFINITY is a large trial in 1600 Australians and New Zealanders with stroke which aims to find out whether taking fluoxetine for 6 months after a stroke improves recovery compared to a placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : GNT1139616
  • 项目类别:
    Boosting Dementia Research Initiative
  • 资助金额:
    $58.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : 1150529
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $58.44万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : GNT1150529
  • 项目类别:
    Targeted Calls for Research
  • 资助金额:
    $86.43万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : 1139616
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $39.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
国内基金
海外基金
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
Multi-decadeurbansubsidencemonitoringwithmulti-temporaryPStechnique
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    80万元
  • 批准年份:
    2022
  • 负责人:
    Timo Balz
  • 依托单位:
High-precision force-reflected bilateral teleoperation of multi-DOF hydraulic robotic manipulators
  • 批准号:
    52111530069
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    10万元
  • 批准年份:
    2021
  • 负责人:
    徐兵
  • 依托单位:
大地电磁强噪音压制的Multi-RRMC技术及其在青藏高原东南缘-印支块体地壳流追踪中的应用